Scheduling Manager, Process Development

Overview

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

We’re currently recruiting for a Scheduling Manager to join our Process Development Team. In this role you will be providing essential scheduling activities to support delivery of the ongoing high-quality work conducted within Process Development (PD) at OXB, playing a key part in advancing our mission and making a real difference.

Responsibilities

• Supporting the implementation of scheduling tools within Process Development
• Carrying out scheduling duties for the PD department including:
  • High level client programme scheduling specifically for PD activities, ensuring all external client and internal project work packages are accurately scheduled
  • Lead PD input to OXB Capacity Planning Meetings and New Client Proposal Meetings
  • Coordination of scheduling for upstream, downstream and analytics team activities
  • Coordination of PD equipment / facility maintenance with engineering scheduling manager
  • Forecasting laboratory equipment capacity and resource requirements for PD based on internal project and external client demands
  • Working with the team to forecast stock requirements based on planned and forecasted lab work
• Working closely with PD Directors and Leads to provide current and future resourcing models
• Working in accordance with the OXB quality management system.

Qualifications

• Good standard of secondary education A level or equivalent in English, Maths and Science
• Proven experience working within a previous scheduling role
• Experience of working within a Laboratory/Pharma manufacturing environment would be beneficial.
• Knowledge of digital scheduling systems and Enterprise Resource Planning Systems (ERP).
• Demonstrated ability to work independently and to manage multiple activities either through direct supervision or in collaboration with a project team
• Good computer literacy skills working with Microsoft office suite.
• Fluency oral communication and interpersonal skills in written and spoken English

About Us

OXB is a quality and innovation-led viral vector CDMO with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, we have more than 25 years of experience in viral vectors; the driving force behind the majority of gene therapies.

OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. OXB’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods, and depth of regulatory expertise.

Why Join Us?

• Competitive total reward packages
• Wellbeing programmes that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State-of-the-art labs and manufacturing facilities
• A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.

We offer

Oxford Biomedica is a quality and innovation-led viral vector CDMO that enables its clients to deliver life-changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, Oxford Biomedica has more than 25 years of experience in viral vectors, the driving force behind the majority of gene therapies.

Cell and gene therapy is the treatment of disease by the delivery of therapeutic genetic material (DNA or RNA), into a patient’s cells. One highly effective approach to delivering genetic information is to re-engineer existing viruses to be safe delivery vehicles (vectors) to insert the genetic material into patients’ cells. This can be achieved either by directly administering the vector to the patient (often referred to as in vivo gene therapy), or by first introducing the genetic material to cells or tissue outside of the body, before administering the cells or tissue into the patient (often referred to as ex vivo gene therapy or gene-modified cell therapy).

Oxford Biomedica collaborates with some of the world\’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV) and adenoviral vectors. Oxford Biomedica\’s world-class capabilities span from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.